Recruit breast cancer patients and collect clinical and epidemiologic data and biospecimens
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700293P
- Awardee
-
The Chinese University Of Hong Kong UEI WEGQBM2FDJN3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $120,000
Award facts
- Opportunity
-
- 4438290 Solicitation number
- Contract value 100% obligated
- $120,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to The Chinese University of Hong Kong for $120,000 on June 13, 2017, to recruit breast cancer patients and collect clinical, epidemiologic data, and biospecimens. Performance occurs in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of June 19, 2018.
Quick answers
Who was awarded contract HHSN261201700293P?
HHSN261201700293P was awarded to The Chinese University Of Hong Kong by National Cancer Institute (National Institutes of Health) on June 13, 2017.
How much is contract HHSN261201700293P worth?
The government has obligated $120,000 on HHSN261201700293P.
Was contract HHSN261201700293P competed?
The extent of competition for HHSN261201700293P was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award